Matches in Wikidata for { <http://www.wikidata.org/entity/Q91210335> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q91210335 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91210335 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91210335 description "scientific article published on 31 October 2019" @default.
- Q91210335 description "wetenschappelijk artikel" @default.
- Q91210335 description "наукова стаття, опублікована 31 жовтня 2019" @default.
- Q91210335 name "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 name "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 type Item @default.
- Q91210335 label "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 label "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 prefLabel "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 prefLabel "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 P1433 Q91210335-657231E1-FDA1-4F7F-AF85-608DCA4EA102 @default.
- Q91210335 P1476 Q91210335-AC7FC845-E02B-4E87-BF78-67AA66182F84 @default.
- Q91210335 P2093 Q91210335-2840ED40-9297-40B6-971D-3D5F482E6A8B @default.
- Q91210335 P2093 Q91210335-449276E5-A79A-4264-99B1-BF7C9D34905E @default.
- Q91210335 P2093 Q91210335-4C5D89B6-F803-40E6-A87F-E63ED06F2362 @default.
- Q91210335 P2093 Q91210335-66F71E14-EE7A-490B-9198-B73BE3386A03 @default.
- Q91210335 P2093 Q91210335-E93B0C0A-9E48-40CA-8C47-1F21583E788C @default.
- Q91210335 P31 Q91210335-F984C8A7-33D7-4FFA-917B-28197A377CE2 @default.
- Q91210335 P356 Q91210335-61421493-4B48-46CD-8736-3F3C79DFCC64 @default.
- Q91210335 P50 Q91210335-D95B777A-AEBC-44D1-9B4C-894531B41CDA @default.
- Q91210335 P577 Q91210335-E691EE1A-B7F5-48A9-8334-B9FD9EAC5643 @default.
- Q91210335 P698 Q91210335-301A5C1A-F5FF-4878-9B63-AA355C55F4DD @default.
- Q91210335 P921 Q91210335-7D0E3AED-942B-4AD5-AC34-F6A4EB9355C8 @default.
- Q91210335 P356 J.SAPHARM.2019.10.015 @default.
- Q91210335 P698 31706950 @default.
- Q91210335 P1433 Q15817708 @default.
- Q91210335 P1476 "Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment" @default.
- Q91210335 P2093 "Anirban Basu" @default.
- Q91210335 P2093 "David L Veenstra" @default.
- Q91210335 P2093 "Kangho Suh" @default.
- Q91210335 P2093 "Mark Bounthavong" @default.
- Q91210335 P2093 "Melissa L D Christopher" @default.
- Q91210335 P31 Q13442814 @default.
- Q91210335 P356 "10.1016/J.SAPHARM.2019.10.015" @default.
- Q91210335 P50 Q46003952 @default.
- Q91210335 P577 "2019-10-31T00:00:00Z" @default.
- Q91210335 P698 "31706950" @default.
- Q91210335 P921 Q17154378 @default.